ARWR  valuation analysis

Basics
Name: Arrowhead Pharmaceuticals, Inc
Description: Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 04, 2021
Market cap: $8.32B (490th)
Sales(TTM): $79.84M (1260th)
Earnings(TTM): -$102.61M (1085th)

Value
FFER: 6.82 (why)
Actual price: $80.63
FFEThis is Arrowhead Pharmaceuticals, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $12.96
Quantile: ARWR is very expensive given its fundamentals.
Prices as of EOD 2021-03-02
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Arrowhead Pharmaceuticals, Inc's earnings decreased from $53.26M to -$102.61M in the last year.
  • Arrowhead Pharmaceuticals, Inc's operating income decreased from $45.39M to -$112.36M in the last year.
Earnings / MarketCap
Arrowhead Pharmaceuticals, Inc
"Biotechnology" industry
Sales / MarketCap
Arrowhead Pharmaceuticals, Inc
"Biotechnology" industry
Book / MarketCap
Arrowhead Pharmaceuticals, Inc
"Biotechnology" industry
Equity / Assets
Arrowhead Pharmaceuticals, Inc
"Biotechnology" industry